Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01902459 · ClinicalTrials.gov registry record · Phase 4
EVARREST™ Fibrin Sealant Patch Post-Market Study
A Phase 4 study, sponsored by Ethicon.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT01902459: Completed Phase 4 study, sponsored by Ethicon.
NCT01902459 is a Phase 4 study that has completed, run by Ethicon. The registered enrollment target is 150 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01902459, a Phase 4 study, has completed, sponsored by Ethicon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) surgery.
Primary Outcome
Number of subjects experiencing a thromboembolic event as reported in the adverse events/serious adverse event safety set. the Safety set consists of all subjects on whom procedure is started.
Interventions
- OTHER Standard of Care
- BIOLOGICAL EVARREST™ Fibrin Sealant Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2013-07-01 |
| Est. Completion | 2015-09-01 |
| Phase | Phase 4 |
What the finished NCT01902459 record still lists
NCT01902459 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT01902459 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01902459 about?
NCT01902459 is a clinical study titled "EVARREST™ Fibrin Sealant Patch Post-Market Study". The objective of this study is to evaluate the clinical utility of EVARREST™ Fibrin Sealant Patch (Fibrin Pad) as an adjunct to hemostasis in soft tissue bleeding during intra-abdominal (stomach area), retroperitoneal (hip and stomach area), pelvic (hip area) and non-cardiac thoracic (chest area) su...
What is the current status of trial NCT01902459?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2013-07-01. Estimated completion is 2015-09-01.
What interventions are being tested in trial NCT01902459?
The interventions under investigation include: Standard of Care (OTHER), EVARREST™ Fibrin Sealant Patch (BIOLOGICAL).
Who is sponsoring clinical trial NCT01902459?
This trial is sponsored by Ethicon, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01902459's enrollment target sits among peer trials
150 533rd of 2000 higher than 1,436 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI